Professor Pablo Fernandez Penas
People_

Professor Pablo Fernandez Penas

MD, PhD, FACD
Professor of Dermatology
Joint Head, Specialty of Dermatology
Head of Dermatology, Westmead Hospital
Lead, Melanoma and Skin Cancer Group, WIMR
NSW Lead, ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis
Principal Investigator, WARC
Professor Pablo Fernandez Penas

Pablo Fernández-Peñas is Professor in Dermatology at Sydney Medical School (The University of Sydney), and Senior Medical Practitioner (Academic) at Westmead Hospital. He was appointedHead of the Department of Dermatology at Westmead Hospital in 2010, and Director of the Centre for Translational Skin Research in 2017. At theSkin and Cancer Foundation Australia, he has been theHead of Education (2011-15) and Head of Research (2008-2018).

Pablo is a MD (1989) and PhD (2000) of the Universidad Autonoma of Madrid, Spain. Previously, Staff Specialist (Dermatology) at Hospital Universitario de la Princesa (Madrid, Spain, 1995-2007) and Clinical and Honorary Professor at the Universidad Autonoma (Madrid, Spain, 1991-2007), he moved to Sydney in 2007 to pursue his academic career.

He has received further training in Bioethics (1997), Informed Consent (1997), and Protection of Human Research Subject (2005); in Management of Clinical Units (2000), Management of Clinical Processes (2006), and Clinical Leadership (2007-8), and he is University Expert on Advanced Methods in Applied Statistics (2005-6).

He has been Board Member of the Spanish (1998-2006) and the European (2003-2009) Academies of Dermatology and Venereology. He was funding member and first convenor of the Spanish Dermatology Research Working Group (2006-7). He is memberof the Spanish Committee for the standard EU 60335-2-27, AENOR-CENELEC since 2004.

Since he moved to Sydney in 2007, he participated in the development of the Department of Dermatology at Westmead Hospital, focusing in providing high quality dermatology care to public patients in Western Sydney. He was appointed Head of the Department in 2010, opened the Dermatology Comprehensive Clinical Centre in 2010 and the Dermatology Research and Clinical Trials Unit in 2012, both at Westmead Hospital, and the Centre for Translational Skin Research in 2017.

To progres studies in Oncodermatology, he is building strong links with the Westmead Cancer Care Centre and the Skin and Cancer Foundation Australia, opened the first Cutaneous Lymphoma Clinic and cutaneous Graft versus Host Disease Clinics in NSW, and he is participating in melanoma, cutaneous lymphoma, basal cell carcinoma, non-melanoma skin cancer, and actinic keratosis clinical trials. His teams at Westmead Hospital and at the Skin and Cancer Foundation Australia are progressing research projects in Merkel Cell Carcinoma, Mohs surgery, the Cutaneous Side Effectos of oncological medications, and Squamous Cell Carcinoma and Melanoma.

His PhD was on adhesion and motility of keratinocytes (J Invest Dermatol 111: 19-24; 1998; J Invest Dermatol 114: 1126-1135; 2000). His thesis was awarded the Extraordinary Prize of the School of Medicine (Universidad Autonoma, Madrid, Spain) and the Doctorate Prize of the National Royal Academy of Medicine (Spain).

He has worked in celular photobiology with melanocytes and dendritic cells (J Invest Dermatol 125:334-42; 2005). He has studied the possible photoprotective effect of a number of molecules in in vitro studies using keratinocytes, melanocytes, and dendritic cells in collaboration with private industry (Exp Dermatol 16:823-829; 2007). His interest in photobiology led him to join the Spanish Committee for the EU 60335-2-27 standard (Safety of household and similar electrical appliances: Particular requirements for appliances for skin exposure to ultraviolet and infrared radiation) in 2004, and was selected the Spanish representative in the Maintenance Team of the International Electrotechnical Commission (IEC/TC61/MT16) for this standard (IEC 60335-2-27) in the same year. During 2006-8, he was the convenor of the CENELEC/TC61 Ad Hoc Working Group EN 60335-2-27 that adapted the EU 60335-2-27 to the recommendations of the Scientific Committee of the EU (Actas Dermosifiliogr. 2008;99:429-30).

Prof Pablo Fernandez-Peñas interest in Graft versus Host Disease (GVHD) commenced in 1995. He has published a number of original papers describing clinical findings of Acute GVHD, Lichenoid chronic GVHD and Sclerodermatoid chronic GVHD (Arch Dermatol 138: 924-934; 2002) and the role of rituximab (Bone Marrow Transplant 47:737-8; 2012) to treat chronic cutaneous GVHD. He has also published a review of the condition (Australas J Dermatol 51: 1-10; 2010) and the therapy (Am J Clin Dermatol 5: 403-416; 2004) including phototherapy (Australas J Dermatol 56:93-9, 2015) and a few case reports and case series. Prof Pablo Fernandez-Peñas has been invited to give lectures on GVHD in national and international meetings.

In 2005, he visited the Department of Dermatology at Harvard University (Boston, USA) and participated in several research studies on Merkel Cell Carcinoma (Arch Dermatol 142: 685-690; 2006, J Am Acad Dermatol 2008; 58: 375-381;J Invest Dermatol. 2009; 129(6): 1547-55).

Another research interest of Prof Pablo Fernandez-Peñas is Quality of Life in Dermatology. Since 1998 (Int J Dermatol 39: 907-912; 2000), he has been working in the impact of dermatology conditions such as psoriasis or acne in the Quality of Life of patients, and recently skin cancer (Australas J Dermatol 56:70-6, 2015). This is an active research line in his department.

Since he moved to Sydney in 2007, Pablo has focused in Oncodermatology. He is participating in melanoma, cutaneous lymphoma, basal cell carcinoma, non-melanoma skin cancer, and actinic keratosis clinical trials. He has established an Oncodermatology Tissue Bank and Immunohistochemistry and Proteomic platforms. Recent publications include a number of papers on the cutaneous side effects of new treatments for metastatic melanoma (Lancet Oncol 14:e11-8;2013; JAMA dermatology 151:1103-9, 2015; J Am Acad Dermatol 72:809-15 e1, 2015), its mechanisms (Pigment Cell Melanoma Res 25:569-72;2012; Exp Dermatol 25:394-5, 2016) and management (J Clin Oncol 30:e165-7;2012; Actas Dermosifiliogr 108:6-16, 2017). He has also explored other areas of oncodermatology: Mohs surgery, photodynamic therapy and the use of nicotinamide for skin cancer prevention (N Engl J Med 373:1618-26, 2015). His team is also interested in human behaviour related to skin cancer (Eur J Dermatol 24:85-93, 2014; J Cancer Educ, 2016). He has been invited to give lectures in national and international meetings.

He has 187 publications (h: 33, 4534 citations [Google Scholar]), participated in research projects with total grant funding of $14.5M, and has participated in 60+ clinical trials in oncodermatology [metastatic melanoma (BRAF and MEK inhibitors, anti PD1 molecules), basal cell carcinoma (heghehog inhibitor), squamous cell carcinoma (nicotinamide), actinic keratosis (photodynamic therapy, ingenol mebutate)] and inflammatory cutaneous diseases (psoriasis, hidradenitis, pyoderma gangrenosum).

(Last update in Feb 2019)

His main fields of interest are immunology, onco-dermatology (including cutaneous lymphoma, melanoma and non-melanoma skin cancer, and the cutaneous effects of graft versus host disease), quality of life in dermatology, and information technologies and codification.

He provides dermatology teaching to the Sydney Medical School students at Westmead and Nepean Clinical Schools, including lectures, and clinical tutorials. There is an Elective program for medical students and opportunities for international medical students.

He supervises students for the Sydney Medical School MD program andUniversity of Sydney Honours, Master and PhD Students.

He is the coordinator of the Unit of Study: Essential Dermatology (DERM5001), part of several courses at the University of Sydney (Graduate Diplomas, Graduate Certificates and Masters), and participates in other Units of Study (AMED3001, AMED3888, SEXH5200).

He teaches dermatology registrars and unaccredited traineesduring their appointments at Westmead Hospital.

He has established two international programs:

- Onco-Dermatology Fellow position (1 year program) for overseas dermatologists to disseminate the knowledge and skills to diagnose and treat skin cancers.

- Observership (3 months program) for overseas dermatology registrars.

He is interested in providing dermatology knowledge to General Practitioners, other medical specialties, nurses, and general public, and has colaborated in multiple meetings and lectures.

His other main teaching topic is Research Methodology and Planning Research Projects, and he has lectured about Methodology, Designing Proyects, Ethics, Writing and publishing papers, etc, both local and internationally.

2018 Presidential Citation. Australasian College of Dermatology
2016 Order of Civil Merit (Officer). High Distinction awarded by the King of Spain.
Cancer, Infection and Immunological Conditions, Healthy Ageing
Project titleResearch student
Remote assessment of cutaneous lymphoma using 3D photographyKelvin TRUONG

Publications

Journals

  • Choon, S., Frez, M., Huei, H., Le Huu, D., Kim, T., Morita, A., Oon, H., Fernandez Penas, P., Rajatanavin, N., Robinson, S., et al (2024). Asia-Pacific consensus recommendations on the management of generalized pustular psoriasis. Journal of Dermatology. [More Information]
  • Jones, G., Calao, M., Begun, J., Sin, S., Kouhkamari, M., Young, E., Fernandez Penas, P., Watts, A., Östör, A. (2024). Impact of a Patient Support Program on time to discontinuation of adalimumab in Australian adult patients with immunemediated inflammatory diseases-an observational study. PloS One, 19(2024-06-06 00:00:00). [More Information]
  • Simpson, E., Yang, F., Pierce, E., Bieber, T., Fernandez Penas, P., de Bruin-Weller, M., Lio, P., Chu, C., Ezzedine, K., Agell, H., et al (2024). Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2). Advances in Therapy. [More Information]

2024

  • Choon, S., Frez, M., Huei, H., Le Huu, D., Kim, T., Morita, A., Oon, H., Fernandez Penas, P., Rajatanavin, N., Robinson, S., et al (2024). Asia-Pacific consensus recommendations on the management of generalized pustular psoriasis. Journal of Dermatology. [More Information]
  • Jones, G., Calao, M., Begun, J., Sin, S., Kouhkamari, M., Young, E., Fernandez Penas, P., Watts, A., Östör, A. (2024). Impact of a Patient Support Program on time to discontinuation of adalimumab in Australian adult patients with immunemediated inflammatory diseases-an observational study. PloS One, 19(2024-06-06 00:00:00). [More Information]
  • Simpson, E., Yang, F., Pierce, E., Bieber, T., Fernandez Penas, P., de Bruin-Weller, M., Lio, P., Chu, C., Ezzedine, K., Agell, H., et al (2024). Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2). Advances in Therapy. [More Information]

2023

  • Pulido-Pérez, A., Descalzo-Gallego, M., Arias-Santiago, S., Molina-Leyva, A., Gilaberte, Y., Fernández-Crehuet, P., Husein-ElAhmed, H., Viera-Ramírez, A., Fernandez Penas, P., Taberner, R., et al (2023). [Translated article] Nonvenereal Infections in Spanish Dermatology Clinics: Results of the DIADERM Study. Actas Dermo-Sifiliograficas, 114(6), T472-T478. [More Information]
  • Teh, R., Azimi, A., Pupo, G., Ali, M., Mann, G., Fernandez Penas, P. (2023). Genomic and proteomic findings in early melanoma and opportunities for early diagnosis. Experimental Dermatology, 32(2), 104-116. [More Information]
  • Caffery, L., Janda, M., Miller, R., Abbott, L., Arnold, C., Caccetta, T., Guitera, P., Shumack, S., Fernandez Penas, P., Mar, V., et al (2023). Informing a position statement on the use of artificial intelligence in dermatology in Australia. Australasian Journal of Dermatology, 64(1), e11-e20. [More Information]

2022

  • Mahumud, R., Janda, M., Soyer, H., Fernandez Penas, P., Mar, V., Morton, R. (2022). Assessing the value of precision medicine health technologies to detect and manage melanoma. Medical Journal of Australia, 217(6), 275-278. [More Information]
  • Pennington, T., Zhao, C., Colebatch, A., Fernandez Penas, P., Guitera, P., Burke, H., Scolyer, R., Menzies, A., Carlino, M., Lo, S., Long, G., Saw, R. (2022). Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma. Australasian Journal of Dermatology, 63(2), e133-e137. [More Information]
  • Joseph, J., Truong, K., Smith, A., Fernandez Penas, P. (2022). Dermatology inpatient consultations in a tertiary hospital – a retrospective analysis. International Journal Of Dermatology, 61(1), 48-53. [More Information]

2021

  • Joseph, J., Truong, K., Smith, A., Fernandez Penas, P. (2021). Adherence to suggestions after dermatology consultation in a tertiary hospital – a retrospective analysis. Australasian Journal of Dermatology, 62(4), e582-e585. [More Information]
  • Watts, C., McLoughlin, K., Goumas, C., Van Kemenade, C., Aitken, J., Soyer, H., Fernandez Penas, P., Guitera, P., Scolyer, R., Morton, R., Menzies, S., Caruana, M., Kang, Y., Mann, G., Madronio, C., Armstrong, B., Thompson, J., Cust, A., et al (2021). Association between Melanoma Detected during Routine Skin Checks and Mortality. JAMA Dermatology, 157(12), 1425-1436. [More Information]
  • Thyssen, J., Buhl, T., Fernandez Penas, P., Kabashima, K., Chen, S., Lu, N., DeLozier, A., Casillas, M., Ständer, S. (2021). Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7. Dermatology and Therapy, 11(5), 1599-1611. [More Information]

2020

  • Lickliter, J., Gan, H., Voskoboynik, M., Arulananda, S., Gao, B., Nagrial, A., Zou, J., Zhang, L., Luo, S., Lahn, M., Fernandez Penas, P., et al (2020). A first-in-human dose finding study of camrelizumab in patients with advanced or metastatic cancer in Australia. Drug Design, Development and Therapy, 14, 1177-1189. [More Information]
  • Cheng, H., Fernandez Penas, P. (2020). Allergic Contact Dermatitis of the Anogenital Region in Men and Women. Journal of Lower Genital Tract Disease, 24(2), 221-224. [More Information]
  • Azimi, A., Yang, P., Ali, M., Howard, V., Mann, G., Alexander, K., Fernandez Penas, P. (2020). Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology, 140(1), 212-222. [More Information]

2019

  • Hwang, S., Park, J., Wakade, D., Chou, S., Byth Wilson, K., Fernandez Penas, P. (2019). Cutaneous adverse events of anti-programmed death 1 antibodies combined with anti-cytotoxic T-lymphocyte-associated protein 4 therapy use in patients with metastatic melanoma. Melanoma Research, 29(2), 172-177. [More Information]
  • Gonzalez-Cantero, A., Arias-Santiago, S., Buendía-Eisman, A., Molina-Leyva, A., Gilaberte, Y., Fernández-Crehuet, P., Husein-ElAhmed, H., Viera-Ramírez, A., Fernandez Penas, P., Taberner, R., et al (2019). Do Dermatologic Diagnosis Change in Hot vs Cold Periods of The Year? A Sub-Analysis of the DIADERM National Sample (Spain 2016). Actas Dermo-Sifiliograficas, 110(9), 734-743. [More Information]
  • Venning, V., Moreno Bonilla, G., Stewart, T., Lee, S., Fernandez Penas, P. (2019). Increased collaboration between Mohs and plastic surgeons in the surgical management of skin cancer in Australia. Australasian Journal of Dermatology, 61(1), 85-87. [More Information]

2018

  • Hwang, S., Fernandez Penas, P. (2018). Adverse Reactions to Biologics: Melanoma (Ipilimumab, Nivolumab, Pembrolizumab). Current Problems in Dermatology, 53, 82-92. [More Information]
  • Zhao, C., Hwang, S., Consuegra, G., Chou, S., Fernandez Penas, P. (2018). Anti-programmed cell death-1 therapy-associated bullous disorders: a systematic review of the literature. Melanoma Research, 28(6), 491-501. [More Information]
  • Polcz, M., Sebaratnam, D., Fernandez Penas, P. (2018). Atypical fibroxanthoma management: Recurrence, metastasis and disease-specific death. Australasian Journal of Dermatology, 59(1), 10-25. [More Information]

2017

  • Hwang, S., Wakade, D., Kong, B., Carlino, M., Chou, S., Fernandez Penas, P. (2017). Acute Truncal Lymphedema Secondary to Axillary Metastatic Melanoma Presenting Like Cellulitis. Case Reports in Medicine, 2017, 1-3. [More Information]
  • Hwang, S., Anforth, R., Carlos Minano, G., Fernandez Penas, P. (2017). Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management. Actas Dermo-Sifiliograficas, 108(1), 6-16. [More Information]
  • Nguyen, Y., Chou, S., Fernandez Penas, P. (2017). Cutaneous Nodules in the Genital Area in a Patient With Chronic Graft-vs-Host Disease. JAMA Dermatology, 153(5), 465-466. [More Information]

2016

  • Hwang, S., Carlos Minano, G., Chou, S., Wakade, D., Carlino, M., Fernandez Penas, P. (2016). Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies. Melanoma Research, 26(4), 413-416. [More Information]
  • McKenzie, C., Chen, A., Choy, B., Fernandez Penas, P., Damian, D., Scolyer, R. (2016). Classification of high risk basal cell carcinoma subtypes: experience of the ONTRAC study with proposed definitions and guidelines for pathological reporting. Pathology, 48(5), 395-397. [More Information]
  • See, J., Shumack, S., Murrell, D., Rubel, D., Fernandez Penas, P., Salmon, R., Hewitt, D., Foley, P., Spelman, L. (2016). Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia. Australasian Journal of Dermatology, 57(3), 167-174. [More Information]

2015

  • Carlos, G., Anforth, R., Chou, S., Clements, A., Fernandez Penas, P. (2015). A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab. Melanoma Research, 25(3), 265-268. [More Information]
  • Chen, A., Martin, A., Choy, B., Fernandez Penas, P., Dalziell, R., McKenzie, C., Scolyer, R., Dhillon, H., Vardy, J., Kricker, A., St George, G., Chinniah, N., Halliday, G., Damian, D. (2015). A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. New England Journal of Medicine, 373(17), 1618-1626. [More Information]
  • George, L., Hamann, I., Chen, K., Choi, J., Fernandez Penas, P. (2015). An analysis of the dermatological uses of mycophenolate mofetil in a tertiary hospital. Journal of Dermatological Treatment, 26(1), 63-66. [More Information]

2014

  • Uribe, P., Anforth, R., Kefford, R., Fernandez Penas, P. (2014). Acneiform eruption in a patient with metastatic melanoma after ceasing combination dabrafenib/trametinib therapy. Melanoma Research, 24(5), 501-503. [More Information]
  • Anforth, R., Liu, M., Nguyen, B., Uribe, P., Kefford, R., Clements, A., Long, G., Fernandez Penas, P. (2014). Acneiform eruptions: A common cutaneous toxicity of the MEK inhibitor trametinib. Australasian Journal of Dermatology, 55(4), 250-254. [More Information]
  • Fernandez-Morano, T., De Troya-Martin, M., Rivas-Ruiz, F., Blazquez-Sanchez, N., Del Boz-Gonzalez, J., Fernandez Penas, P., Buendia-Eisman, A. (2014). Behaviour, attitudes and awareness concerning sun exposure in adolescents on the Costa del sol. European Journal of Dermatology, 24(1), 85-93. [More Information]

2013

  • Anforth, R., Fernandez Penas, P., Long, G. (2013). Cutaneous toxicities of RAF inhibitors. The Lancet Oncology, 14(1), e11-e18. [More Information]
  • Affandi, A., Anforth, R., Chou, S., Fernandez Penas, P. (2013). Non-evolving linear facial plaque. Clinical and Experimental Dermatology, 38(6), 681-683. [More Information]
  • Carlos Minano, G., Pablo, U., Fernandez Penas, P. (2013). Rational use of topical corticosteroids. Australian Prescriber, 36(5), 158-161. [More Information]

2012

  • Doggett, S., Dwyer, D., Fernandez Penas, P., Russell, R. (2012). Bed Bugs: Clinical Relevance and Control Options. Clinical Microbiology Reviews, 25(1), 164-192. [More Information]
  • Fernandez Penas, P., Jones-Caballero, M., Espallardo, O., Garcia-Diez, A. (2012). Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis. British Journal of Dermatology, 166(4), 884-887. [More Information]
  • Anforth, R., Blumetti, T., Kefford, R., Sharma, R., Scolyer, R., Kossard, S., Long, G., Fernandez Penas, P. (2012). Cutaneous Manifestations of Dabrafenib (GSK2118436): A Selective Inhibitor of Mutant BRAF in patients with Metastatic Melanoma. British Journal of Dermatology, 167(5), 1153-1160. [More Information]

2011

  • Chinniah, N., Fernandez Penas, P. (2011). Laptop dermatitis. Medical Journal of Australia, 194(7), 371-371. [More Information]
  • Fessa, C., Fernandez Penas, P. (2011). Multiple facial plaques: A case study. Australian Family Physician, 40(7), 506-508. [More Information]
  • Dixit, S., Fernandez Penas, P. (2011). Sarcoidosis, Hypercalcemia and Calcium-sensing Receptor Mutation: A Case Report. Acta Dermato-Venereologica, 91(4). [More Information]

2010

  • Fessa, C., Sharma, R., Fernandez Penas, P. (2010). Cutaneous epithelioid angiosarcoma occurring at a peristomal site. Journal Of The American Academy Of Dermatology, 63(2), e55-e56. [More Information]
  • Fernandez Penas, P., Zeng, L. (2010). Many faces of graft-versus-host disease. Australasian Journal of Dermatology, 51(1), 1-10; quiz 11. [More Information]
  • Lim, P., Paver, R., Fernandez Penas, P. (2010). Mohs micrographic surgery at the Skin and Cancer Foundation Australia, 10 years later (1997 vs 2007). Journal Of The American Academy Of Dermatology, 63(5), 832-835. [More Information]

2009

  • Paulson, K., Lemos, B., Feng, B., Jaimes, N., Fernandez Penas, P., Bi, X., Maher, E., Cohen, L., Leonard, J., Granter, S., et al (2009). Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. Journal of Investigative Dermatology, 129(6), 1547-1555. [More Information]
  • Goiriz, R., Fernandez Penas, P., Pérez-Gala, S., Delgado-Jiménez, Y., Aragüés, M., García-Diez, A., Fraga, J., Figuera, A., Fernández-Herrera, J. (2009). Stage IV cutaneous acute graft-versus-host disease. Clinical and histological study of 15 cases. Journal of the European Academy of Dermatology and Venereology, 23(12), 1398-1404. [More Information]

2008

  • Heath, M., Jaimes, N., Lemos, B., Mostaghimi, A., Wang, L., Fernandez Penas, P., Nghiem, P. (2008). Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. Journal Of The American Academy Of Dermatology, 58(3), 375-381. [More Information]
  • Goiriz, R., Fernandez Penas, P., Delgado-Jimenez, Y., Fernandez-Herrera, J., Aragues-Montanes, M., Fraga, J., Garcia-Diez, A. (2008). Cutaneous lichenoid graft-versus-host disease mimicking lupus erythematosus. Lupus, 17(6), 591-5. [More Information]
  • Pedraz, J., Fernandez Penas, P., Garcia-Diez, A. (2008). Pachyonychia congenita and hidradenitis suppurativa: no response to infliximab therapy. Journal of the European Academy of Dermatology and Venereology, 22(12), 1500-1501. [More Information]

2007

  • Janczyk, A., Garcia-Lopez, M., Fernandez Penas, P., Alonso-Lebrero, J., Benedicto, I., Lopez-Cabrera, M., Gonzalez, S. (2007). A Polypodium leucotomos extract inhibits solar-simulated radiation-induced TNF-α and iNOS expression, transcriptional activation and apoptosis. Experimental Dermatology, 16(10), 823-829. [More Information]
  • Nam-Cha, S., Guhl, G., Fernandez Penas, P., Fraga, J. (2007). Alopecia syphilitica with detection of Treponema pallidum in the hair follicle. Journal Of Cutaneous Pathology, 34(Suppl 1), 37-40. [More Information]
  • Goiriz, R., Guhl-Millan, G., Penas, P., Fernandez-Herrera, J., Dauden, E., Dauden, E., Fraga, J., Garcia-Diez, A. (2007). Eosinophilic folliculitis following allogeneic peripheral blood stem cell transplantation: case report and review. Journal Of Cutaneous Pathology, 34 Suppl 1(0), 33-36. [More Information]

2006

  • Ruiz-Genao, D., Fernandez Penas, P., Dauden, E., Garcia-F-Villalta, M., Fraga, J., Garcia-Diez, A. (2006). Acute severe form of lichenoid graft-versus-host disease after donor lymphocyte infusions. Journal of the European Academy of Dermatology and Venereology, 20(5), 632-634. [More Information]
  • Goiriz, R., Delgado-Jimenez, Y., Fernandez Penas, P., Fraga, J., Garcia-Diez, A., Fernandez-Herrera, J. (2006). Atypical early follicular graft-vs-host disease. Archives of Dermatology, 142, 1237-1238.
  • Pérez, L., Fernandez Penas, P., Atienzar, M., García-Díez, A. (2006). Implication of MT1-MMP in the maturation steps of benign melanocytic nevi. Journal Of Cutaneous Pathology, 33(2), 139-144. [More Information]

2005

  • Garcia-Rio, I., Fernandez Penas, P., Garcia-Diez, A., McLean, W., Smith, F. (2005). A severe case of pachyonychia congenita type I due to a novel proline mutation in keratin 6a. British Journal of Dermatology, 152(4), 800-802. [More Information]
  • Fernandez Penas, P., García-López, M., Barreiro del Río, O. (2005). Inhibicion de la motilidad de celulas de melanoma con ARN de interferencia de CD9 [Inhibition of the motility of melanoma cells using interference RNA against CD9]. Actas Dermo-Sifiliograficas, 96(1), 30-36. [More Information]
  • Garcia-Lopez, M., Barreiro del Río, O., Garcia-Diez, A., Sanchez-Madrid, F., Fernandez Penas, P. (2005). Role of Tetraspanins CD9 and CD151 in Primary Melanocyte Motility. Journal of Investigative Dermatology, 125(5), 1001-1009. [More Information]

2004

  • Ã�lvarez-Ruiz, S., Fernandez Penas, P., Fernández-Herrera, J., Sanchez-Perez, J., Fraga, J., García-Díez, A. (2004). Maculopapular eruption with enlarged macrophages in eight patients receiving G-CSF or GM-CSF. Journal of the European Academy of Dermatology and Venereology, 18(3), 310-313. [More Information]

2003

  • Hoffmann, K., Gambichler, T., Rick, A., Kreutz, M., Perotti, R., Andreassi, L., Césarini, J., Fischer, T., Frosch, P., Lindskov, R., Fernandez Penas, P., et al (2003). Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer-aided analysis of data from pigmented skin lesions using digital dermoscopy. British Journal of Dermatology, 149(4), 801-809. [More Information]

Selected Grants

2023

  • The identification of protein signatures and the use of scarless skin biopsies to achieve more reliable diagnoses through proteomic analysis, Teh R, Fernandez Penas P, Azimi A, Australian Melanoma Research Foundation/Research Grants

2022

  • A flagship lightsheet, confocal and live cell 4D microscope to turbocharge translational cancer research at the Westmead Health Precinct, George J, Graham J, Robinson P, O'Neill G, Hau E, Fernandez Penas P, Gottlieb D, Ahern V, Cesare A, Schlegel P, Cancer Institute NSW/Equipment Grant